Are low magnesium levels in type 1 diabetes associated with electromyographical signs of polyneuropathy?

Magnesium Research

Volumn 13, Issue 3, 2000, Pages 197-203

  Engelen, W ^a   Bouten, A ^a   De Leeuw, I ^a   De Block, C ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Diabetic complications; Diabetic neuropathy; Magnesium depletion

Indexed keywords

MAGNESIUM;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; ELECTROMYOGRAPHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; NERVE CONDUCTION; PATHOPHYSIOLOGY; PILOT STUDY; POLYNEUROPATHY;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; ELECTROMYOGRAPHY; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; NEURAL CONDUCTION; PILOT PROJECTS; POLYNEUROPATHIES;

EID: 0034277556     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Tosiello, L. (1996): Hypomagnesemia and diabetes mellitus. A review of clinical implications Arch. Intern. Med. 56, 1143-1148.
2. Garland, H.O. (1992): New experimental data on the relationship between diabetes mellitus and magnesium. Magnes. Res. 5, 193-202.
3. Paolisso, G., Scheen, A., D'Onofrio, F. & Lefèbvre, P. (1990): Magnesium and glucose homeostasis. Diabetologia 33, 511-514.
4. Sjögren A., Florén C. H. & Nilsson A. (1986): Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. Diabetes 35, 459-463.
5. Me Intosh T.K., Vink R., Yamakami I. & Faden A.I. (1989): Magnesium protects against neurological deficit after brain injury. Brain Res. 482, 252-260.
6. Durlach J. (1985): Données sur la biologie du magnésium. In Le magnésium en pratique clinique. Paris: J.B. Baillière.
7. Chutkow J.G. (1990): Magnesium and the peripheral (extradural) nervous system: metabolism, neurophysiological functions and clinical disorders. In Compendium on magnesium and its role in biology, nutrition and physiology. Vol. 26. pp. 417-440, eds H. Sigel & A. Sigel. New York: Dekker.
8. Anast C.S. & Gardner D.W. (1981): Magnesium metabolism. In Disorders of mineral metabolism: pathophysiology of calcium, phosphorus and magnesium. pp. 423-522. eds F. Bronner & J.W. Cobwen. New York: Academic Press.
9. De Leeuw I., Vertommen J. & Abs R. (1978): The magnesium content of trabecular bone in diabetic subjects. Biomedicine 29, 16-17.
10. Fujii, S., Takemura, T., Wada, M., Akai, T. & Okuda, K. (1982): Magnesium levels in plasma, erythrocytes and urine in patients with diabetes mellitus. Horm. Metabol. Res. 14, 161-162.
11. Van Roelen W., Van Gaal L., Van Rooy P. & De Leeuw I.: (1985): Serum and erythrocyte magnesium levels in type I and type II diabetics. Acta Diabetol. Lat. 22, 185-190.
12. Millart H., Durlach V. & Durlach J. (1995): Red blood cell magnesium concentrations: analytical problems and significance. Magnes. Res. 8, 65-76.
13. Liveson J.A. & Dong M.A. (1992): Laboratory reference for clinical neurophysiology. Philadelphia: F.A. Davis Company.
14. Mather H.M., Nisbet J.A., Burton G.H., Poston G.J., Bland J.M., Baily P.A. & Pilkington T.R.E. (1979): Hypomagnesemia in diabetes. Clin. Chim. Acta 95, 235-242.
15. McNair P., Christiansen C., Madsbad S., Lauritzen E., Faber O., Binder C. & Transbol I. (1978): Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes 27, 1075-1077.
16. Ceriello A., Giugliano D., Dello Russo P. & Passariello N. (1982): Hypomagnesemia in relation to diabetic retinopathy. Diabetes Care 5, 558-559.
17. Rasmussen H.S., Norregrad P., Lindeneg O., McNair P., Baker V. & Balslev S. (1986): Intravenous magnesium infusion in acute myocardial Infarction. Lancet 1, 234.
18. Seelig M. (1989). Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations - magnesium and chloride loss in refractory potassium repletion. Am. J. Cardiol. 63, 4G-21G.
19. Pirart J. (1978) Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1, 168-188.
20. Soroku Y. (1995): Pathology and pathogenetic mechanisms of diabetic neuropathy. Diabetes Metab. Rev. 11, 193-225.
21. Paolisso G., Tirelli A., Coppola L., Verrazzo G., Pizza G., Sgambato S. & D'Onofrio F.(1989): Magnesium administration reduces platelet hyperaggregability in NIDDM. Diabetes Care 12, 167-168.
22. Greene D.A., Lattimer S.A. & Sima A.A. F. (1989): Sorbitol, phosphoinositides and sodium potassium - ATPase in the pathogenesis of diabetic complications. N. Eng. J. Med. 316: 10, 599-606.
23. Greene D.A., Lattimer S.A. & Sima A.A. F. (1988): Are Disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy? Diabetes 37, 688-693
24. Grafton G. & Baxter M.A. (1992): The role of magnesium in diabetes mellitus. A possible mechanism for the development of diabetic complications. J. Diabetes Complications 6, 143-149.
25. 2+ in etiology of diabetic complications. Diabetes 41, 35-39.
26. Van Dam P.S., Van Asbeck B.S., Erkelens D.W., Marx J.J.M., Gispen W.H. & Bravenboer B. (1995): The Role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab. Rev. 11, 181-192.
27. Cameron N.E., Cotter M.A., Archibald V., Dines K.C. & Maxfield E.K. (1994): Anti-oxidant and pro-oxidant effects on nerve conduction velocity endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 37, 449-459.
28. Bravenboer B., Kappelle A.C., Hamers F.P.T., Van Buren T., Erkelens D.W. & Gispen W.H (1992): Potential use of gluthation for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rats. Diabetologia 35, 813-817.
29. Cotter M.A., Love A., Watt M.J., Cameron N. E. & Dines K.C. (1995): Effects of natural free radical scavengers on peripheral nerve and neurovascular functions in diabetic rats. Diabetologia 38, 1285-1294.
30. Karasu C., Dewhurst M., Stevens E.J. & Tomiinson D.R. (1995): Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia 38, 129-134.
31. Freedman A.M., Mak I.T., Stafford R.E., Dickens B.F., Cassidy M.M., Muesing R.A. & Weglicki W.B. (1992): Erythrocytes from magnesium-deficient hamsters display an enhanced susceptibility to oxidative stress. Am. J. Physiol. 262, C1371-C1375.
32. Rayssiguier, Y., Gueux, E. & Weiser, D. (1981): Effect of magnesium deficiency on lipid metabolism in rats fed a high carbohydrate diet. J. Nutr. 11, 1876-1883.